The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.
Vascular Endothelial Growth Factor Induces Expression of Connective Tissue Growth Factor via KDR, Flt1, and Phosphatidylinositol 3-Kinase-Akt-dependent Pathways in Retinal Vascular Cells
Open accessAbstract
Fibroblastic proliferation accompanies many angiogenesis-related retinal and systemic diseases. Since connective tissue growth factor (CTGF) is a potent mitogen for fibrosis, extracellular matrix production, and angiogenesis, we have studied the effects and mechanism by which vascular endothelial growth factor (VEGF) regulates CTGF gene expression in retinal capillary cells. In our study, VEGF increased CTGF mRNA levels in a time- and concentration-dependent manner in bovine retinal endothelial cells and pericytes, without the need of new protein synthesis and without altering mRNA stability. VEGF activated the tyrosine receptor phosphorylation of KDR and Flt1 and increased the binding of phosphatidylinositol 3-kinase (PI3-kinase) p85 subunit to KDR and Flt1, both of which could mediate CTGF gene induction. VEGF-induced CTGF expression was mediated primarily by PI3-kinase activation, whereas PKC and ERK pathways made only minimal contributions. Furthermore, overexpression of constitutive active Akt was sufficient to induce CTGF gene expression, and inhibition of Akt activation by overexpressing dominant negative mutant of Akt abolished the VEGF-induced CTGF expression. These data suggest that VEGF can increase CTGF gene expression in bovine retinal capillary cells via KDR or Flt receptors and the activation of PI3-kinase-Akt pathway independently of PKC or Ras-ERK pathway, possibly inducing the fibrosis observed in retinal neovascular diseases.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Vascular endothelial growth factor induced by hypoxia may mediate hypoxia-initiated angiogenesis
Shweiki, D., Itin, A., Soffer, D., & Keshet, E. (1992) · Nature · doi:10.1038/359843a0 · Cited by 4,617
Pendurthi, U. R., Allen, K. E., Ezban, M., & Rao, L. V. M. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.19.14632 · Cited by 145
Cited by
Katso, R., Okkenhaug, K., Ahmadi, K., White, S., Timms, J., & Waterfield, M. D. (2001) · Annual Review of Cell and Developmental Biology · doi:10.1146/annurev.cellbio.17.1.615 · Cited by 1,204
Ivkovic, S., Yoon, B. S., Popoff, S. N., Safadi, F. F., Libuda, D. E., Stephenson, R. C., Daluiski, A., & Lyons, K. M. (2003) · Development · doi:10.1242/dev.00505 · Cited by 713
Angiogenesis-Independent Endothelial Protection of Liver: Role of VEGFR-1
LeCouter, J., Moritz, D. R., Li, B., Phillips, G. L., Liang, X. H., Gerber, H.-P., Hillan, K. J., & Ferrara, N. (2003) · Science · doi:10.1126/science.1079562 · Cited by 679
Statins induce angiogenesis, neurogenesis, and synaptogenesis after stroke
Chen, J., Zhang, Z. G., Li, Y., Wang, Y., Wang, L., Jiang, H., Zhang, C., Lu, M., Katakowski, M., Feldkamp, C. S., et al. (2003) · Annals of Neurology · doi:10.1002/ana.10555 · Cited by 538
Inoki, I., Shiomi, T., Hashimoto, G., Enomoto, H., Nakamura, H., Makino, K.-I., Ikeda, E., Takata, S., Kobayashi, K.-I., & Okada, Y. (2002) · The FASEB Journal · doi:10.1096/fj.01-0332fje · Cited by 372
Arteriolar and venular patterning in retinas of mice selectively expressing VEGF isoforms
Stalmans, I., Ng, Y.-S., Rohan, R., Fruttiger, M., Bouché, A., Ÿuce, A., Fujisawa, H., Hermans, B., Shani, M., Jansen, S., et al. (2002) · Journal of Clinical Investigation · doi:10.1172/jci0214362 · Cited by 358
The pathogenesis of diabetic retinopathy: old concepts and new questions
Cai, J., & Boulton, M. (2002) · Eye · doi:10.1038/sj.eye.6700133 · Cited by 344
Gene regulation of connective tissue growth factor: new targets for antifibrotic therapy?
Blom, I. E., Goldschmeding, R., & Leask, A. (2002) · Matrix Biology · doi:10.1016/s0945-053x(02)00055-0 · Cited by 338
Chou, E., Suzuma, I., Way, K. J., Opland, D., Clermont, A. C., Naruse, K., Suzuma, K., Bowling, N. L., Vlahos, C. J., Aiello, L. P., et al. (2002) · Circulation · doi:10.1161/hc0302.102143 · Cited by 337
Self-citationYoshiji, H., Kuriyama, S., Yoshii, J., Ikenaka, Y., Noguchi, R., Hicklin, D. J., Wu, Y., Yanase, K., Namisaki, T., Yamazaki, M., et al. (2003) · Gut · doi:10.1136/gut.52.9.1347 · Cited by 307
Brigstock, D. R. (2002) · Angiogenesis · doi:10.1023/a:1023823803510 · Cited by 301
Perspectives on diabetic retinopathy
Aiello, L. M. (2003) · American Journal of Ophthalmology · doi:10.1016/s0002-9394(03)00219-8 · Cited by 282
Self-citationHypoxic induction of Ctgf is directly mediated by Hif-1
Higgins, D. F., Biju, M. P., Akai, Y., Wutz, A., Johnson, R. S., & Haase, V. H. (2004) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00245.2004 · Cited by 282
Yang, F., Tuxhorn, J. A., Ressler, S. J., McAlhany, S. J., Dang, T. D., & Rowley, D. R. (2005) · Cancer Research · doi:10.1158/0008-5472.can-05-1702 · Cited by 278
Pericytes regulate VEGF-induced endothelial sprouting through VEGFR1
Eilken, H. M., Diéguez-Hurtado, R., Schmidt, I., Nakayama, M., Jeong, H.-W., Arf, H., Adams, S., Ferrara, N., & Adams, R. H. (2017) · Nature Communications · doi:10.1038/s41467-017-01738-3 · Cited by 270
Connective Tissue Growth Factor Is a Mediator of Angiotensin II–Induced Fibrosis
Rupérez, M., Lorenzo, O., Blanco-Colio, L. M., Esteban, V., Egido, J., & Ruiz-Ortega, M. (2003) · Circulation · doi:10.1161/01.cir.0000089129.51288.ba · Cited by 267
Cannabinoids Inhibit the Vascular Endothelial Growth Factor Pathway in Gliomas
Blázquez, C., González-Feria, L., Álvarez, L., Haro, A., Casanova, M. L., & Guzmán, M. (2004) · Cancer Research · doi:10.1158/0008-5472.can-03-3927 · Cited by 255
Phosphatidylinositol 3-kinase (PI3K) inhibitors as cancer therapeutics
Akinleye, A., Avvaru, P., Furqan, M., Song, Y., & Liu, D. (2013) · Journal of Hematology & Oncology · doi:10.1186/1756-8722-6-88 · Cited by 254
Eisenhofer, G., Huynh, T.-T., Pacak, K., Brouwers, F. M., Walther, M. M., Linehan, W. M., Munson, P. J., Mannelli, M., Goldstein, D. S., & Elkahloun, A. G. (2004) · Endocrine-Related Cancer · doi:10.1677/erc.1.00838 · Cited by 207
“Expression of CTGF and CYR61 can be induced by VEGF (Suzuma et al. 2000), and both regulate the production and function of numerous extracellular proteins involved in angiogenic extracellular matrix remodeling, including other mitogens, such as VEGF (Brigstock 2002, Hashimoto et al.”
He, Z., Opland, D. M., Way, K. J., Ueki, K., Bodyak, N., Kang, P. M., Izumo, S., Kulkarni, R. N., Wang, B., Liao, R., et al. (2006) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.0000209500.15801.4e · Cited by 94
Self-citationKuiper, E. J. (2006) · Archives of Ophthalmology · doi:10.1001/archopht.124.10.1457 · Cited by 89
Zhao, X., Pan, J., Li, W., Yang, W., Qin, L., & Pan, Y. (2018) · International Journal of Nanomedicine · doi:10.2147/ijn.s176928 · Cited by 75
Antitumorigenic effects of cannabinoids beyond apoptosis.
Freimuth, N., Ramer, R., & Hinz, B. (2010) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.109.157735 · Cited by 71
Chintala, H., Liu, H., Parmar, R., Kamalska, M., Kim, Y. J., Lovett, D., Grant, M. B., & Chaqour, B. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.386565 · Cited by 43
Connective tissue growth factor in Alzheimer’s disease
UEBERHAM, U., UEBERHAM, E., GRUSCHKA, H., & ARENDT, T. (2003) · Neuroscience · doi:10.1016/s0306-4522(02)00670-x · Cited by 42
Hasan, A., Pokeza, N., Shaw, L., Lee, H.-S., Lazzaro, D., Chintala, H., Rosenbaum, D., Grant, M. B., & Chaqour, B. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.198689 · Cited by 39
Van Geest, R. J., Lesnik-Oberstein, S. Y., Tan, H. S., Mura, M., Goldschmeding, R., Van Noorden, C. J. F., Klaassen, I., & Schlingemann, R. O. (2012) · British Journal of Ophthalmology · doi:10.1136/bjophthalmol-2011-301005 · Cited by 141
Metadata
- Authors
- Suzuma, K., Naruse, K., Suzuma, I., Takahara, N., Ueki, K., Aiello, L. P., & King, G. L.
- Venue
- Journal of Biological Chemistry
- Publisher
- Elsevier BV
- Published
- 2000-12
- Volume
- 275
- Issue
- 52
- Pages
- 40725-40731
- ISSN
- 0021-9258 (ISSN-L)
- OpenAlex
- W2030790832
- Cited by
- 240
- References
- 2
- FWCI
- 5.86
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.